AMANDA BARSON: Open Payments
NPI 1053183095 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,503 in 76 payments from 20 companies in 2025. Trend: 2023 $228 · 2024 $1,441 · 2025 $1,503
Food & beverage: $1,503
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $223 |
| AstraZeneca Pharmaceuticals LP | 6 | $183 |
| Axsome Therapeutics, Inc. | 6 | $153 |
| Otsuka America Pharmaceutical, Inc. | 8 | $151 |
| PFIZER INC. | 12 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $111 |
| Lundbeck LLC | 5 | $95 |
| Novo Nordisk Inc | 5 | $81 |
| ABBVIE INC. | 3 | $60 |
| Lilly USA, LLC | 2 | $49 |
Products named: REXULTI, NURTEC ODT, REPATHA, OTEZLA, AIRSUPRA, GLASSIA, Auvelity, Symbravo.
Industry payments across CO — which companies pay providers there.
